From 14 December 2020 through 31 May 2022 (persons 18–39 years) and 20 August 2022 (persons 5–17 years), 320 potential cases of myocarditis/pericarditis were identified 1 to 98 days after 6 992 340 vaccine doses as part of primary series COVID-19 vaccination, with 224 (70%) verified. Of these, 137 (61%) occurred 0 to 7 days after vaccination; 18 were after the first dose (of 3 562 311 doses administered) and 119 were after the second dose (of 3 430 029 doses administered).
In all age groups, incidence per million doses 0 to 7 days after vaccination was numerically higher in male than in female persons and after dose 2, although confidence intervals were wide and overlapped across sex for some age groups. Incidence was highest for male adolescents ages 12 to 15 years and 16 to 17 years following dose 2.
From 24 September 2021 through 20 August 2022, 101 potential cases of myocarditis/pericarditis were identified 1 to 98 days after 1 848 723 first booster doses, with 77 (76%) verified with a median onset of 4.5 days after vaccination; 39 cases (51%) were verified in the first week versus 38 during the subsequent 13 weeks.
In all age groups, incidence 0 to 7 days after first booster was higher for male compared to female persons, with adolescent males having the highest incidence in 16- to 17-year-olds and in 12- to 15-year-olds. In adults for whom both vaccine products were available, post-booster incidence was higher in male than in female adults and higher in males aged 18 to 29 compared to males aged 30 to 39.
Thousands of American teenagers may have suffered heart inflammation after getting a Covid jab, a study suggests.
Researchers found up to one in 7,000 boys aged 12 to 15 years old developed myocarditis after receiving the Pfizer vaccine.
The condition — which is mild for most but can cause a recurrent heart palpitation in rare cases — was most common after the second dose.
Dr Peter McCullough MD is America’s leading cardiologist and one of its most articulate and fearless sceptics about the official Covid narrative. He talks to James about needless ‘Covid’ deaths, the importance of early treatment, the deliberate suppression of effective cures and his concerns about vaccine side effects, including the increased incidence of myocarditis especially among young men.
Nature published a comprehensive study this week on cardiovascular risk including a total of over 11 million patients that has made a few headlines. The aim was to identify the cause of increased cardiac pathology. It should have been a very simple study comparing four groups:
Not infected and never vaccinated
Not infected and vaccinated
Infected but not vaccinated
Infected and vaccinated
It is hard to believe the authors did not look at these groups, but whatever was found when comparing them remains a mystery.
Instead, the following groups were compared:
Not infected and never vaccinated data from 2017
Not infected, including vaccinated and not vaccinated
Infected but not vaccinated
Infected with vaccinated people included but using modelled adjustments
When studies with huge datasets use modelling and fail to share data prior to their adjustments alarm bells should start ringing. Therefore, I took a deeper dive to see what else was questionable.
The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been comprehensively characterized. Here we used national healthcare databases from the US Department of Veterans Affairs to build a cohort of 153,760 individuals with COVID-19, as well as two sets of control cohorts with 5,637,647 (contemporary controls) and 5,859,411 (historical controls) individuals, to estimate risks and 1-year burdens of a set of pre-specified incident cardiovascular outcomes. We show that, beyond the first 30 d after infection, individuals with COVID-19 are at increased risk of incident cardiovascular disease spanning several categories, including cerebrovascular disorders, dysrhythmias, ischemic and non-ischemic heart disease, pericarditis, myocarditis, heart failure and thromboembolic disease. These risks and burdens were evident even among individuals who were not hospitalized during the acute phase of the infection and increased in a graded fashion according to the care setting during the acute phase (non-hospitalized, hospitalized and admitted to intensive care). Our results provide evidence that the risk and 1-year burden of cardiovascular disease in survivors of acute COVID-19 are substantial. Care pathways of those surviving the acute episode of COVID-19 should include attention to cardiovascular health and disease.
Four months ago, I had my second dose of the Pfizer Covid-19 vaccine. I work for the NHS and fully support Britain’s vaccination campaign, so it was a simple decision for me to make. I had no problems with my first dose and I knew that the vaccines have been found to be highly effective and safe, preventing up to 96 per cent of Covid hospitalisations.
The day after my second dose I began to feel some aches and pains, but I gave little thought to the vaccine and carried on as normal. Four days later though my chest was seriously aching. I tried various stretches and painkillers but my symptoms grew worse. Then there was a sharp pain, piercing into the left side of my chest, near my heart. After a quick call to NHS 111, they sent me directly to Accident & Emergency, where I was strapped up to an electrocardiogram (ECG) machine and given blood tests to see if I was having a heart attack. I’m in my early thirties and relatively healthy, with no family history of heart disease or underlying conditions, and I’d never felt this sensation before.
Christopher Chope MP raises the figures for damage caused by Covid-19 vaccines in Parliament: “There’s a lot more damage being done to our citizens as a result of Covid-19 vaccinations than in any other vaccination program in history.”
Teenage boys are six times more likely to suffer from heart problems from the vaccine than be hospitalised from Covid-19, a major study has found.
Children who face the highest risk of a “cardiac adverse event” are boys aged between 12 and 15 following two doses of a vaccine, according to new research from the US.
JCVI member Professor Adam Finn said that the latest data from paediatric cardiologists in the US shows that there are concerns about the long-term side effects of COVID-19 vaccine for children.
We spoke to Professor Anthony Harnden, the deputy chair of the Joint Committee on Vaccination and Immunisation, and asked him why they had ruled out vaccines for healthy 12 to 15-year-olds.
THE CENTERS for Disease Control and Prevention’s safety committee has provided an update on the association between Pfizer-BioNTech and Moderna COVID-19 vaccines and heart inflammation.
On 23 June the US Centers for Disease Control and Prevention’s safety committee said there was a “likely association” between the Pfizer-BioNTech and Moderna COVID-19 vaccines and myocarditis (the medical term for heart inflammation) and pericarditis (inflammation of the tissue that surrounds the heart) in some young adults. The CDC’s Advisory Committee on Immunization Practices said there was a higher than expected number of reports of heart inflammation in people aged 16-24 who had received the mRNA vaccines but that the benefits of vaccination still clearly outweighed the risks.
More than 280 teens & young men suffer heart inflammation after Pfizer or Moderna Covid jab – sparking CDC ’emergency’
The CDC and other health regulators have been investigating heart inflammation cases after Israel’s Health Ministry reported that it had found a likely link to the condition in young men who received the Pfizer vaccine.
More than half of the cases reported to the US Vaccine Adverse Event Reporting System (VAERS) after people had received their second dose of either the Pfizer or Moderna vaccines were in people between the ages of 12 and 24, the CDC said.
A higher-than-expected number of young men have experienced heart inflammation after their second dose of the mRNA COVID-19 shots from Pfizer/BioNTech and Moderna, according to data from two vaccine safety monitoring systems, the U.S. Centers for Disease Control and Prevention (CDC) said on Thursday.
…There were 283 observed cases of heart inflammation after the second vaccine dose in those aged 16 to 24 in the VAERS data. That compares with expectations of 10-to-102 cases for that age range based on U.S. population background incidence rates, the CDC said.
Alex talks with Dr. Byram Bridle, an Associate Professor on Viral Immunology at the University of Guelph about new peer-reviewed studies that suggests there may be terrifying reasons side effects such as heart inflammation, VITT (Vaccine induced Thrombosis and Thrombocytopenia) , and other serious issues may occur in those who have been vaccinated.
- New scientific information that has helped us understand why the vaccine problems are happening.
- This is backed up by well-known peer-reviewed scientific publications.
- SARS-CoV-2 has a spike protein on its surface which is what it allows us to infect our bodies.
- Vaccines get the cells in our body to manufacture the spike protein.
- In theory, if we can mount an immune response to this protein, we can prevent the virus from infecting the body.
- When studying the disease, cardio-vascular problems, bleeding and clotting have been associated with severe COVID-19.
- The spike protein is almost entirely responsible for the damage to the cardio-vascular system.
- If you inject the purified spike protein into blood of lab animals, they get all sorts of damage to the cardio-vascular system.
- The assumption up until know is that the new COVID-19 vaccinations behave like other vaccines: they stay at the injection site.
- However, a FOI request has revealed a bio-distribution study that shows the spike protein of the new COVID-19 vaccines gets into the blood post-vaccination and accumulate in tissues such as the spleen, bone marrow, liver, adrenal glands and ovaries.
- It’s been known for a long time that the spike protein is a pathogenic protein–it’s a toxin.
- We now have evidence that the new vaccines gets into blood circulation. When in circulation, the spike protein can bind to the receptors on our platelets and the cells that line our blood vessels.
- When this happens, it can either cause clotting or bleeding.
- It can cross the blood-brain barrier and cause neurological damage.
- There is also evidence that the antibodies can be transferred through breast milk (study not yet accepted). The could be evidence that suckling infants experiencing bleeding disorders in the gastrointestinal tract.
- This has implications for blood donations, sucking infants and people who are not at risk from COVID-19–that includes all our children.
- We made a big mistake. We thought the spike protein was a great target antigen. We didn’t know the spike protein itself was a pathogenic protein.
- By vaccinating people we are inadvertently inoculating them with a toxin that can cause damage.
- Will we be rendering young people infertile?